Ihr Broker

  • DAX 0,70
  • EUR/USD 0,50
  • GOLD 0,30

Nur Spreads

Keine Kommission

Jetzt registrieren

CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren.

SYNLAB AG, DE000A2TSL71

SYNLAB AG, DE000A2TSL71

04.10.2021 - 09:03:35

SYNLAB expands partnership with Feedtrail to gain real-time patient and customer feedback

Investor contact SYNLAB: Mark Reinhard, SYNLAB +49 (0) 170 118 3753Mark.Reinhard@synlab.com Media contact Feedtrail: Ashley Worrall + 1 919 366 7523pr@feedtrail.com ?

About SYNLAB

SYNLAB, (ISIN: DE000A2TSL71, SYMBOL: SYAB) is the largest European clinical laboratory and medical diagnostic services company and offers a full range of innovative and reliable medical diagnostics for patients, practising doctors, clinics and the pharmaceutical industry. Providing the leading level of service within the industry, SYNLAB is the partner of choice for diagnostics in human and veterinary medicine. The Group continuously innovates medical diagnostic services for the benefit of patients and customers. SYNLAB operates in 36 countries across four continents and holds leading positions in most markets. More than 20,000 employees, including over 1,200 medical experts, as well as a large number of other specialists such as biologists, chemists and laboratory technicians, contribute every day to the Group's worldwide success. SYNLAB carries out ~500 million laboratory tests per year and achieved revenues of EUR 2.6 billion in 2020. More information can be found on www.synlab.com

About Feedtrail

With Feedtrail XM, healthcare organizations can learn and deliver what matters most to patients, providers, caregivers, and employees. Our secure, cloud-based experience management (XM) solutions and advanced data analytics enable customer experience teams to engage and connect with the right people at the right time, uncover prescriptive insights, and take purposeful action to drive continuous improvement and measurable results across the lifecycle of care. Over 70 innovative health systems across 4,000 sites in 14 countries already use Feedtrail to uncover explicit opportunities to improve human-centered care and advance better outcomes for people and the business of healthcare. Learn more www.feedtrail.com. You can also follow us on LinkedIn, Facebook and Twitter.

04.10.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English Company: SYNLAB AG Moosacher Stra?e 88 80809 Munich

Germany Phone: +49 1701183753 E-mail: ir@synlab.com Internet: www.synlab.com/ ISIN: DE000A2TSL71 WKN: A2TSL7 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange EQS News ID: 1237679 ? End of News DGAP News Service

1237679??04.10.2021?

@ dgap.de